Karuna Therapeutics

-$1.90 (-1.64%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KRTX and other stocks, options, and ETFs commission-free!

About KRTX

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.

CEO
Steven Marc Paul
Employees
63
Headquarters
Boston, Massachusetts
Founded
2009

KRTX Key Statistics

Market Cap
3.34B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.80K
High Today
$118.25
Low Today
$111.83
Open Price
$115.35
Volume
150.11K
52 Week High
$146.97
52 Week Low
$69.58

KRTX Earnings

-$1.38
-$0.92
-$0.46
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$1.38 per share
Actual
-$1.10 per share

You May Also Like

UNTY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure